Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17113008 | GENE EXPRESSION ANALYSIS TECHNIQUES USING GENE RANKINGS AND STATISTICAL MODELS FOR IDENTIFYING BIOLOGICAL SAMPLE CHARACTERISTICS | December 2020 | July 2022 | Allow | 19 | 3 | 1 | Yes | No |
| 17108958 | MACHINE LEARNING METHOD FOR PROTEIN MODELLING TO DESIGN ENGINEERED PEPTIDES | December 2020 | July 2022 | Allow | 19 | 2 | 1 | Yes | No |
| 17108890 | Protein Structure Prediction from Amino Acid Sequences Using Self-Attention Neural Networks | December 2020 | November 2023 | Allow | 36 | 1 | 0 | Yes | No |
| 17001804 | CHEMICAL REACTION NETWORK FOR ESTIMATING CONCENTRATION OF CHEMICAL SPECIES BASED ON AN IDENTIFIED PATTERN OF OUTPUT CHEMICAL SPECIES | August 2020 | May 2023 | Allow | 33 | 2 | 2 | Yes | No |
| 16919154 | METHODS AND SYSTEMS FOR PATIENT BASELINE ESTIMATION | July 2020 | November 2023 | Allow | 40 | 2 | 0 | No | No |
| 16946534 | MEASURING AND REMOVING NOISE IN STOCHASTIC SIGNALS FROM A NANOPORE DNA SEQUENCING SYSTEM DRIVEN BY AN ALTERNATING SIGNAL | June 2020 | March 2022 | Allow | 21 | 1 | 0 | No | No |
| 16893213 | Biological Deposit Labeling And Tracking Including Isotope, Rare Earth Metal Or Mitochondria Tags | June 2020 | April 2024 | Allow | 46 | 1 | 0 | No | No |
| 16883833 | GENE EXPRESSION PROFILING FROM FFPE SAMPLES | May 2020 | July 2023 | Abandon | 38 | 1 | 0 | No | No |
| 16877729 | BIOLOGICS ENGINEERING VIA APTAMOMIMETIC DISCOVERY | May 2020 | November 2023 | Allow | 42 | 2 | 0 | Yes | No |
| 16854378 | Methods and Systems for Use in Cancer Prediction | April 2020 | March 2024 | Allow | 47 | 3 | 0 | Yes | No |
| 16851578 | PERSONALIZED MEDICAL MONITORING AND NOTIFICATIONS THEREFOR | April 2020 | January 2024 | Allow | 45 | 3 | 1 | Yes | Yes |
| 16819972 | METHODS AND SYSTEMS FOR PREDICTING THE RISK OF TRANSGENE SILENCING | March 2020 | April 2024 | Abandon | 49 | 1 | 0 | Yes | No |
| 16796748 | METHODS FOR AMPLIFICATION OF CELL-FREE DNA USING LIGATED ADAPTORS AND UNIVERSAL AND INNER TARGET-SPECIFIC PRIMERS FOR MULTIPLEXED NESTED PCR | February 2020 | January 2021 | Abandon | 11 | 1 | 1 | Yes | No |
| 16728259 | SPATIAL ANALYTICAL MICROBIAL IMAGING | December 2019 | September 2024 | Abandon | 57 | 0 | 1 | Yes | No |
| 16727879 | ULTRASOUND DEVICES AND SYSTEMS FOR DETERMINING CONSTITUTIVE RELATIONS AND FIBER ORIENTATION OF SOFT TISSUES | December 2019 | June 2023 | Allow | 42 | 1 | 0 | No | No |
| 16720172 | METHODS FOR IDENTIFYING AGENTS WITH DESIRED BIOLOGICAL ACTIVITY | December 2019 | May 2024 | Abandon | 52 | 0 | 1 | No | No |
| 16708312 | PREDICTING PATIENT RESPONSE TO SODIUM CHANNEL BLOCKERS | December 2019 | June 2024 | Allow | 54 | 2 | 0 | Yes | No |
| 16703792 | FEATURE IDENTIFYING METHOD AND ELECTRONIC DEVICE | December 2019 | September 2023 | Allow | 45 | 2 | 1 | Yes | No |
| 16659154 | MULTI-PARAMETER PHYSIOLOGICAL MAPPING TO A MULTI-DIMENSIONAL COLOR MODEL | October 2019 | October 2023 | Allow | 48 | 1 | 1 | No | No |
| 16565773 | MANIPULATING DROPLET SIZE | September 2019 | October 2023 | Allow | 49 | 1 | 1 | Yes | No |
| 16544316 | Systems for Non-Invasive Assessment of Chromosome Alterations Using Changes in Subsequence Mappability | August 2019 | October 2023 | Allow | 50 | 2 | 0 | Yes | No |
| 16504158 | SIMULATING EVOLUTION OF A TUMOR | July 2019 | December 2023 | Allow | 53 | 2 | 0 | Yes | No |
| 16459049 | IDENTIFACTION OF CANCER BIOMARKERS BY ALIGNMENT OF NUCLEIC ACID SEQUENCES | July 2019 | August 2023 | Allow | 50 | 1 | 0 | Yes | No |
| 16456462 | SYSTEMS AND METHODS FOR PREDICTING THERAPY EFFICACY FROM NORMALIZED BIOMARKER SCORES | June 2019 | August 2023 | Allow | 50 | 4 | 0 | Yes | No |
| 16443968 | SIMULATIONS NETWORKED ACTIVITY USING DYNAMICS- BASED CONSTRAINTS ON REUSABLE NETWORK COMPONENT | June 2019 | April 2023 | Allow | 46 | 1 | 0 | Yes | No |
| 16390648 | TESTING AND REPRESENTING SUSPICION OF SEPSIS | April 2019 | June 2022 | Allow | 38 | 2 | 0 | Yes | No |
| 16383248 | SYSTEM ERROR COMPENSATION OF ANALYTE CONCENTRATION DETERMINATIONS BASED ON PSEUDO-REFERENCE CONCENTRATION AND SIGNAL-BASED ANCHOR PARAMETERS | April 2019 | October 2023 | Allow | 54 | 1 | 1 | Yes | No |
| 16341438 | THE PRIMARY SITE OF METASTATIC CANCER IDENTIFICATION METHOD AND SYSTEM THEREOF | April 2019 | April 2023 | Abandon | 48 | 0 | 1 | No | No |
| 16365048 | EXCLUDING VARIANT PATTERNS FROM SEQUENCES APPARATUS, METHOD, AND STORAGE MEDIUM | March 2019 | August 2024 | Abandon | 60 | 2 | 0 | No | No |
| 16355590 | METHODS USING CHROMATIN-RELATED NUCLEIC ACID SIGNALS FOR PERFORMING CLINICAL ACTIONS | March 2019 | April 2024 | Allow | 60 | 2 | 1 | Yes | No |
| 16279764 | SYSTEMS AND METHODS FOR STIMULATION-RELATED BIOLOGICAL CIRCUIT ELEMENT ANALYSIS AND USE | February 2019 | January 2023 | Allow | 47 | 2 | 1 | Yes | No |
| 16279785 | SYSTEMS AND METHODS FOR STIMULATION-RELATED VOLUME ANALYSIS OF THERAPEUTIC EFFECTS AND OTHER CLINICAL INDICATIONS | February 2019 | December 2022 | Allow | 46 | 1 | 1 | Yes | No |
| 16267778 | Quality score compression apparatus and method for improving downstream accuracy | February 2019 | May 2023 | Allow | 51 | 2 | 0 | Yes | No |
| 16246420 | DETERMINING A NUCLEIC ACID SEQUENCE IMBALANCE USING MULTIPLE MARKERS | January 2019 | March 2023 | Allow | 50 | 2 | 1 | Yes | No |
| 16232928 | METAGENOMICS FOR MICROBIOMES | December 2018 | June 2022 | Allow | 42 | 1 | 0 | Yes | No |
| 16312820 | COGNITIVE CELL WITH CODED CHEMICALS FOR GENERATING OUTPUTS FROM ENVIRONMENTAL INPUTS AND METHOD OF USING SAME | December 2018 | April 2023 | Abandon | 52 | 3 | 2 | No | No |
| 16309489 | PERSONALISED NUTRIENT DOSING WITH ON-GOING FEEDBACK LOOP | December 2018 | June 2022 | Allow | 42 | 1 | 1 | Yes | No |
| 16217718 | Methods for Using Nucleic Acids to Store, Retrieve and Access Information Comprising a Text, Image, Video or Audio Format | December 2018 | August 2022 | Allow | 44 | 2 | 0 | Yes | No |
| 16216770 | ANONYMIZING GENETIC DATASETS IN A DISPARATE COMPUTING ENVIRONMENT | December 2018 | July 2022 | Allow | 43 | 2 | 0 | Yes | No |
| 16214327 | TRANSCRIPTOME-WIDE DESIGN OF SELECTIVE, BIOACTIVE SMALL MOLECULES TARGETING RNA | December 2018 | December 2022 | Allow | 48 | 2 | 1 | Yes | No |
| 16308721 | GRAPHICAL REPRESENTATION OF A DYNAMIC KNEE SCORE FOR A KNEE SURGERY | December 2018 | September 2022 | Allow | 45 | 1 | 0 | Yes | No |
| 16213677 | Methods And Systems For Identifying Hybrids For Use In Plant Breeding | December 2018 | November 2022 | Allow | 48 | 1 | 2 | No | No |
| 16213596 | Methods And Systems For Identifying Progenies For Use In Plant Breeding | December 2018 | March 2023 | Allow | 52 | 1 | 1 | No | No |
| 16202889 | IDENTIFYING KNOWLEDGE GAPS UTILIZING COGNITIVE NETWORK META-ANALYSIS | November 2018 | June 2022 | Allow | 43 | 2 | 0 | Yes | No |
| 16203040 | COMPUTING SYSTEM FOR NORMALIZING COMPUTER-READABLE GENETIC TEST RESULTS FROM NUMEROUS DIFFERENT SOURCES | November 2018 | October 2022 | Allow | 46 | 2 | 0 | No | No |
| 16304890 | ASSESSING THE FUNCTIONAL ABILITY OF A PERSON TO PERFORM A TASK | November 2018 | September 2022 | Allow | 45 | 2 | 0 | No | No |
| 16199701 | SYSTEM AND METHOD FOR PREDICTION-MODEL-BASED DISPLAY OF DISTRIBUTIONS OF HEALTH OUTCOME INFORMATION FOR PATIENT POPULATIONS IN GEOGRAPHICAL AREAS | November 2018 | January 2023 | Allow | 50 | 3 | 1 | Yes | No |
| 16302542 | A SYSTEM TO COMPARE AT LEAST ONE DNA FRAGMENT TO A REFERENCE GENOME | November 2018 | February 2023 | Allow | 51 | 1 | 1 | No | No |
| 16172351 | SYSTEM AND METHOD FOR ANALYZING DISEASES AND DISEASE DEVELOPMENT | October 2018 | July 2024 | Abandon | 60 | 4 | 0 | Yes | Yes |
| 16092372 | NUCLEOLAR DISRUPTION DETERMINATION AND SCORING OF IMAGES | October 2018 | November 2023 | Abandon | 60 | 2 | 1 | No | No |
| 16151217 | DETERMINING MUCOPOLYSACCHARIDOSES AND DECISION SUPPORT TOOL | October 2018 | October 2023 | Allow | 60 | 1 | 0 | Yes | No |
| 16085022 | Compression/Decompression Method and Apparatus for Genomic Variant Call Data | September 2018 | July 2023 | Allow | 58 | 2 | 1 | No | No |
| 16117432 | Recovering Timing Information from DNA Encoded Data | August 2018 | October 2022 | Allow | 49 | 2 | 0 | Yes | No |
| 16034058 | AN ADAPTIVE EXPERT SYSTEM FOR ANALYSIS AND CLASSIFICATION OF DNA SAMPLE DATA | July 2018 | June 2023 | Allow | 59 | 3 | 1 | Yes | No |
| 16030296 | COMPUTER-AIDED DIAGNOSTIC SYSTEM FOR EARLY DIAGNOSIS OF PROSTATE CANCER | July 2018 | July 2022 | Allow | 48 | 1 | 0 | No | No |
| 16028241 | METHOD TO SCREEN HIGH AFFINITY ANTIBODY | July 2018 | October 2022 | Allow | 51 | 1 | 1 | No | No |
| 16011753 | Systems and Methods for the Interpretation of Genetic and Genomic Variants via an Integrated Computational and Experimental Deep Mutational Learning Framework | June 2018 | April 2023 | Abandon | 58 | 1 | 1 | No | No |
| 16062075 | A NATURAL PRODUCT AND GENETIC DATA ANALYSIS AND DISCOVERY SYSTEM, METHOD AND COMPUTATIONAL PLATFORM THEREFOR | June 2018 | July 2023 | Allow | 60 | 2 | 1 | Yes | No |
| 15987713 | VISUALIZATION, COMPARATIVE ANALYSIS, AND AUTOMATED DIFFERENCE DETECTION FOR LARGE MULTI-PARAMETER DATA SETS | May 2018 | October 2022 | Allow | 53 | 2 | 1 | Yes | No |
| 15987541 | SAMPLE ANALYSIS WITH TEST DETERMINATION BASED ON IDENTIFIED CONDITION | May 2018 | August 2022 | Allow | 51 | 2 | 1 | Yes | No |
| 15777316 | Method For Calibrating A Data Set Of A Target Analyte Using A Normalization Coefficient | May 2018 | October 2023 | Allow | 60 | 2 | 1 | Yes | No |
| 15773602 | METHOD AND DEVICE FOR MODELLING HUMAN OR ANIMAL TISSUE | May 2018 | April 2023 | Abandon | 59 | 1 | 1 | No | No |
| 15902855 | Nucleic Acid Based Data Storage Using Enzymatic Bioencryption | February 2018 | November 2022 | Allow | 57 | 3 | 1 | Yes | No |
| 15932273 | Method of Treatment of Disease and Method for Quantifying the Level of Minimal Residual Disease in a Subject | February 2018 | January 2023 | Allow | 59 | 3 | 1 | Yes | No |
| 15865166 | SYSTEMS AND METHODS FOR CHARACTERIZING EXTRACELLULAR VESICLE (EV) POPULATION BY PREDICTING WHETHER THE EV ORIGINATES FROM B, T, OR DENDRITIC CELLS | January 2018 | February 2023 | Allow | 60 | 1 | 1 | Yes | No |
| 15848602 | HEART RATE PATH OPTIMIZER | December 2017 | December 2023 | Allow | 60 | 5 | 1 | Yes | No |
| 15847569 | SYSTEM, METHOD, AND ARTICLE FOR DETECTING ABNORMAL CELLS USING MULTI-DIMENSIONAL ANALYSIS | December 2017 | March 2024 | Allow | 60 | 5 | 1 | Yes | No |
| 15828540 | SYSTEM AND METHOD FOR PHYSIOLOGICAL MONITORING AND FEATURE SET OPTIMIZATION FOR CLASSIFICATION OF PHYSIOLOGICAL SIGNAL | December 2017 | January 2023 | Allow | 60 | 3 | 1 | No | No |
| 15806174 | METHODS FOR CELL LABEL CLASSIFICATION | November 2017 | December 2021 | Allow | 49 | 3 | 1 | No | No |
| 15571023 | A CLINICAL PARAMETER CALCULATION-SIMULATION-MONITORING SYSTEM | October 2017 | June 2023 | Abandon | 60 | 1 | 1 | Yes | No |
| 15728614 | RECONSTRUCTION AND SIMULATION OF NEOCORTICAL MICROCIRCUITRY | October 2017 | August 2023 | Allow | 60 | 6 | 1 | No | No |
| 15722978 | METHOD, STORAGE MEDIUM AND ELECTRICAL DEVICE FOR OBTAINING CYCLE OF PHYSIOLOGICAL SIGNAL | October 2017 | December 2022 | Allow | 60 | 5 | 1 | Yes | No |
| 15700988 | Apparatus and method for determining chemical input | September 2017 | September 2022 | Allow | 60 | 4 | 1 | No | No |
| 15661942 | COPY NUMBER ALTERATION AND REFERENCE GENOME MAPPING | July 2017 | July 2022 | Allow | 59 | 4 | 0 | Yes | No |
| 15639724 | METHOD AND DEVICE FOR ASSESSING FEASIBILITY OF BIOCHEMICAL REACTION IN ORGANISM | June 2017 | March 2023 | Allow | 60 | 3 | 1 | Yes | No |
| 15536307 | METHOD FOR DETERMINING THE FIBRINOGEN CONCENTRATION IN A BIOLOGICAL SAMPLE | June 2017 | October 2022 | Allow | 60 | 5 | 1 | Yes | No |
| 15394138 | METHODS AND SYSTEMS TO TREAT AN INFECTION FROM PHENAZINE CONTAINING BACTERIA AND RELATED COMPOUNDS AND COMPOSITIONS | December 2016 | March 2023 | Allow | 60 | 7 | 1 | Yes | No |
| 15285935 | A METHOD OF FORMULATING A MULTICOMPONENT DRUG USING BASES EVALUATED BY MAHALANOBIS TAGUCHI METHOD | October 2016 | October 2022 | Allow | 60 | 7 | 1 | Yes | No |
| 15257019 | NEURAL OSCILLATION MONITORING SYSTEM | September 2016 | September 2023 | Allow | 60 | 7 | 1 | No | No |
| 15102209 | OLIGONUCLEOTIDE DATA STORAGE ON SOLID SUPPORTS | June 2016 | October 2023 | Allow | 60 | 8 | 1 | No | No |
| 15036951 | METHODS FOR ASSESSING CELL VIABILITY OR PREDICTING CELL RESPONSE TO A TREATMENT USING CELL MOVEMENT | May 2016 | September 2022 | Allow | 60 | 7 | 1 | Yes | No |
| 14326810 | DETERMINING A RECOVERY INDICATOR USING HEART RATE DATA | July 2014 | June 2022 | Allow | 60 | 7 | 1 | Yes | No |
| 12949420 | REAGENT KITS FOR DIAGNOSIS OF HEPATOCARCINOMA | November 2010 | June 2022 | Allow | 60 | 7 | 1 | Yes | Yes |
| 11973583 | Method and system for determining the reliability of forensic interpretation | October 2007 | March 2020 | Abandon | 60 | 12 | 0 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner VANNI, GEORGE STEVEN.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner VANNI, GEORGE STEVEN works in Art Unit 1672 and has examined 84 patent applications in our dataset. With an allowance rate of 83.3%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 51 months.
Examiner VANNI, GEORGE STEVEN's allowance rate of 83.3% places them in the 58% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by VANNI, GEORGE STEVEN receive 2.58 office actions before reaching final disposition. This places the examiner in the 72% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by VANNI, GEORGE STEVEN is 51 months. This places the examiner in the 6% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +19.1% benefit to allowance rate for applications examined by VANNI, GEORGE STEVEN. This interview benefit is in the 61% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 29.0% of applications are subsequently allowed. This success rate is in the 57% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 40.0% of cases where such amendments are filed. This entry rate is in the 62% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 59.3% are granted (fully or in part). This grant rate is in the 60% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.9% of allowed cases (in the 75% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.